An independent tribunal has banned Indian player Parikshit Somani from tennis for four years after rejecting his explanation for a positive drug test, the sport’s integrity body announced Wednesday.
What was the substance?
Trimetazidine, a heart medication prohibited in sport. The 26 year old tested positive at a lower tier event in Astana, Kazakhstan, last year. His career high ranking was 256 in doubles, meaning this tennis doping ban involves a player operating at the margins of the professional game rather than a recognised name.
What was his explanation?
Contamination through food. He said a family member’s medication had entered food prepared for him. The tribunal found the theory scientifically implausible, highly speculative and unconvincing, and concluded at an August hearing that his defence had not established the source of the alleged contamination.
Why is the Valieva comparison being made?
Because the substance and the defence are the same. The Russian figure skater tested positive for trimetazidine before the 2022 Beijing Olympics, and her representatives also attributed it to contamination from a family member’s medication. She received a four year ban as well. A Chinese swimmer was involved in a case featuring the same substance in 2014. The pattern is why tribunals now treat contamination claims involving this drug with particular scepticism.
How high is the bar for a contamination defence?
High, and deliberately so. Under anti doping rules an athlete is responsible for what is in their body, and a positive test shifts the burden onto them. Successfully arguing contamination generally requires identifying the specific source, producing it for testing and demonstrating that the quantity found is consistent with accidental exposure rather than use. A plausible narrative is not sufficient. That structure is why a tennis doping ban of this length follows a rejected explanation rather than a contested finding of fact.
Is the framework fair?
Contested, and worth stating both ways. Supporters of strict liability argue that any weaker standard would make enforcement impossible, since intent cannot be proven and every athlete would claim accident. Critics argue the rules bear hardest on athletes without resources, since mounting a successful contamination defence requires laboratory analysis and specialist legal representation that a player ranked outside the top 250 is unlikely to afford. Both points are true simultaneously.
What does the ban cover?
Everything. Through September 2029 he cannot compete in, coach at or attend events organised by the sport’s governing bodies, the professional tours, the Grand Slams or any national federation. For a player at his ranking and age, a four year exclusion is effectively the end of a career rather than an interruption to one.
Can it be appealed?
Decisions of this kind are ordinarily appealable to the Court of Arbitration for Sport, though nothing in the announcement indicates whether that is intended. The finding stands unless and until it is overturned.
What is the wider context?
Tennis has faced sustained scrutiny over consistency in doping enforcement, with high profile cases resolving on very different terms from cases involving lower ranked players. That comparison will follow this tennis doping ban regardless of the merits, because the perception of a two tier system is now part of how any such decision is received.
